Bharat Biotech on Tuesday submitted Phase III trial data for the Covaxin coronavirus vaccine to the DCGI (Drug Controller General of India), whose SEC (subject expert committee) is expected to meet...
from NDTV News - India-news https://ift.tt/3vSHX1S
Subscribe to:
Post Comments (Atom)
Opposition Notice On Motion To Remove Poll Body Chief Rejected In Parliament
In separate orders, the Speaker and the Rajya Sabha Chairman refused to admit the notices moved under Article 324(5) of the Constitution. ...
-
The government has tweeted a list of phone numbers of all states and Union Territories for people to dial in with their queries and request ...
-
Using a spin on Prime Minister Narendra Modi's monthly address to the nation, Congress leader Rahul Gandhi today urged the central gover...
No comments:
Post a Comment